1 minute reading time (57 words)

Delta Opioid Receptor Identified as Promising Therapeutic Target for Inflammatory Pain Relief

  Delta opioid receptors have a built-in mechanism for pain relief and can be precisely targeted with drug-delivering nanoparticles—making them a promising target for treating chronic inflammatory pain with fewer side effects, according to a new study from an international team of researchers. The study is published in Proceedings of the National Academy of Sciences. Full story.

Related Posts

The AAPM Annual Meeting offers education and networking opportunities for all members of the pain care team.

Learn More